Cocoa is a rich source of fiber and flavonoids with recognized antioxidant and anti-inflammatory potential. The aim of this study was to evaluate the effects of a cocoa-enriched diet on rats with dextran sulfate sodium (DSS)-induced colitis. Wistar rats were fed with either a 5% cocoa diet or standard diet. Colon inflammation was induced by DSS in the drinking water: 5% for six days and 2% over the following nine days. Colitis was assessed by body weight loss, stool consistency and blood presence in stools. A group of animals fed standard diet was treated with quercitrin (1 mg/kg) after colitis establishment. After two weeks of DSS treatment, the colon oxidative and inflammatory status and lymphocyte composition from blood and mesenteric lymph nodes (MLNs) were assessed. The cocoa-fed group did not exhibit amelioration of clinical colitis but displayed higher antioxidant activity than the colitic reference group by the restoration of colon glutathione content and prevention of lipid peroxidation. The cocoa diet showed anti-inflammatory potential because it down-regulated serum tumor necrosis factor-a, colon inducible nitric oxide synthase activity and decreased colon cell infiltration. The lymphocyte composition in MLNs was not modified by drinking DSS, but there was an increase in the proportion of natural killer and regulatory T-cells in the blood. These changes were not modified by cocoa. In conclusion, cocoa intake may help to inhibit the negative oxidative effects consequent to colitis, although this action is not enough to abrogate the intestinal inflammation significantly.
Introduction
Ulcerative colitis (UC) and Crohn's disease (CD) constitute the principal forms of chronic inflammatory bowel disease (IBD). Although the exact etiology of both CD and UC remains unclear, IBD inflammation is thought to result from a complex interaction of genetic and environmental factors that leads to altered immunological responses to gut microbiota. 1 Current treatments for IBD include immunosuppressant or biological drugs blocking key molecules of the inflammatory cascade. However, significant side-effects have been reported, thereby limiting their use. 2 Because of this, the use of complementary or alternative interventions is becoming widespread and an increasing number of studies show the potential of biologically active nutrients, which may play an important role in the immune response modulation of IBD. 3 In this context, since the colon may be subjected to oxidative stress during active inflammation, the incorporation of dietary antioxidants might help to reduce mucosal inflammation. 4 Commonly occurring dietary polyphenols, particularly flavonoids, have been reported to possess remarkable antioxidant and anti-inflammatory capabilities in experimental conditions. 5, 6 Cocoa and cocoabased products are the natural sources of flavan-3-ols such as (2)-epicatechin, (þ)-catechin and their oligomers, the procyanidins. 7 Moreover, cocoa is considered an excellent source of dietary fiber, which retains significant amounts of polyphenolic compounds and plays a key role in their transportation through the gastrointestinal tract. 8 Cocoa procyanidins seem to reach the colon intact, where they are metabolized by the intestinal microbiota into various phenolic acids. 9 Several studies have demonstrated the antioxidant capacity of cocoa flavonoids and their metabolites. 10 In addition, cocoa has exhibited in vitro and in vivo antiinflammatory and regulatory effects on immune cells involved in innate and acquired immunity. 11 -13 As the oral administration of dextran sulfate sodium (DSS) is a widely used and well-characterized model of colitis in rodents and shares clinical and pathological characteristics with human IBD, 14 the aim of this study was to evaluate the effects of a diet containing cocoa on DSS-induced chronic colitis in rats. In particular, we focused on the response of mesenteric lymph nodes (MLNs) and blood lymphocytes and on the assessment of diverse biochemical variables associated with colonic oxidative stress induced by DSS-induced colitis. In addition, the effects of cocoa were compared with those exerted by quercitrin, a glycoside of the flavonoid quercetin with recognized anti-inflammatory activity in the DSS model 6 which was used as a control treatment.
Materials and methods
Reagents DSS of molecular weight 36 -50 kDa was obtained from MP Biomedicals (Illkirch, France). RPMI 1640 medium, glutamine, penicillin, streptomycin and fetal bovine serum were purchased from PAA (Pasching, Austria). Quercitrin was obtained from Extrasynthèse (Genay, France). Defatted Natural Forastero cocoa containing 21.85 mg/g polyphenols (Table 1) was provided by Nutrexpa SL (Barcelona, Spain). All other reagents, unless otherwise stated, were purchased from Sigma-Aldrich (Madrid, Spain).
Animals and diets
Five-week-old female Wistar rats (Harlan, Barcelona, Spain) were housed in cages under controlled conditions of temperature (22 + 28C) and humidity in a 12:12 lightdark cycle. All experimental procedures were reviewed and approved by the Ethical Committee for Animal Experimentation of the University of Barcelona (reference DMAH3874).
Animals had free access to water and chow. The AIN-93M formulation 16 was used as the standard diet. A diet containing 50 g/kg cocoa was produced from a modification of the AIN-93M formula as previously described 12 and was provided for three weeks prior to DSS administration and until the end of the study (Figure 1 ).
Induction and assessment of colitis
Colitis was induced by ad libitum administration of 5% DSS (w/v) in drinking water for six days and 2% DSS for the following nine days. Animals were randomly assigned to four experimental groups (n ¼ 12/group; Figure 1 ): a group receiving a standard diet and water without DSS (REF); a group fed the standard diet and water with DSS (DSS); a group fed the standard diet and water with DSS that was treated daily with quercitrin (1 mg/kg, orally) from the day that the DSS dose was reduced to 2% (DSS-Q); and a group fed the cocoa diet from three weeks prior to DSS drinking and until the end of the study (DSS-C). The dosing protocol for quercitrin was established according to reported studies showing an amelioration of the DSS-induced inflammatory process. 6 Clinical assessment of colitis included daily evaluation of body weight, stool consistency (normal, loose or diarrhea) and the presence of macroscopic blood in the stools. These variables allowed calculating a disease activity index (DAI) with a 0 -4 point severity scale. 17 At the end of the study (Figure 1 ), animals were anesthetized intramuscularly with ketamine (90 mg/kg) and xylazine (10 mg/kg). Blood, MLNs, small intestine and colon were obtained from each animal. MLNs and blood lymphocyte phenotype
MLNs and blood lymphocytes were isolated as previously described. 12 Lymphocyte phenotype was determined by three-color immunofluorescence staining and flow cytometry analysis. Mouse anti-rat monoclonal antibodies (MAb) used here included: fluorescein isothiocyanate (FITC)-conjugated anti-T-cell-receptor (TCR) ab (R73), CD45RA (OX-33), CD4 (OX -35) and CD25 (IL-2Ra chain OX-39) MAb; phycoerythrin-conjugated anti-CD4 (OX-35) and NKR-P1A (10/78) MAb; peridininchlorophyll-protein-conjugated and anti-CD8a (OX-8) MAb (all from BD Biosciences, Madrid, Spain); and allophycocyaninconjugated anti-Foxp3 (FJK-16a) MAb (eBioscience, Frankfurt, Germany). Extracellular and intracellular staining was carried out as in previous studies. 12 Flow cytometry analysis was performed on a Cytomics FC500-MPL cytometer (Beckman Coulter, Miami, FL, USA) and data were analyzed by the software Summit V3.1 (Cytomation, Fort Collins, CO, USA). Lymphocyte subsets were defined as B (CD45RAþ), Th (CD4þTCRabþ), Tc (TCRabþCD8aþ), activated Th (T act ; CD4þCD25þFoxp32) and regulatory Th (T reg ; CD4þCD25þFoxp3þ). Results are expressed as a percentage of positive cells in the total lymphocyte population or, in some cases, are shown as a percentage of positive cells in a specific lymphocyte subset (T act and T reg in Th cells).
Blood leukocyte counts
Total white blood cell counts were determined automatically by means of a Coulter Counter JT hemocytometer (Beckman Coulter) calibrated for rat samples. Differential leukocyte counts were microscopically established in blood smears stained using the May -Grü nwald -Giemsa technique.
Quantification of tumor necrosis factor-a
Serum tumor necrosis factor (TNF)-a concentration was quantified using a commercial rat cytokine bead immunoassay (Bender MedSystems GmbH, Vienna, Austria) following the manufacturer's recommendations. Analysis was performed using a Cytomics FC500-MPL cytometer (Beckman Coulter) and the FlowCytomix Pro2.2.1 program from Bender MedSystems GmbH.
Quantification of secretory-immunoglobulin in small intestine
The small intestine was excised and carefully rinsed with ice-cold phosphate-buffered saline (PBS). The distal half of the small intestine was used to obtain the gut wash for secretory (S)-IgA and S-IgM quantification by enzymelinked immunosorbent assay. 12 
Assessment of the inflammatory and oxidative status of the colon
The colon was excised and carefully rinsed with ice-cold PBS. The total weight and length of the colon were determined to establish intestinal wall thickening and colon shortening, respectively. Thereafter, the colon was opened longitudinally and a transverse section of the damaged distal area was kept for histological analysis. The remaining colon was divided into four longitudinal strips that were immediately frozen in liquid N 2 and stored at 2808C to estimate some inflammatory mediators such as prostaglandin E 2 (PGE 2 ), leukotriene B 4 (LTB 4 ) and inducible nitric oxide synthase activity (iNOS). Thiobarbituric acid reactive substances (TBARS) and total glutathione (GSH) content were measured as antioxidant indicators.
A longitudinal colon stripe from each animal was homogenized in 0.1 mol/L sodium phosphate buffer pH 7.4 (200 g/L) containing 1 mmol/L ethylenediaminetetraacetic acid and 10 mmol/L indomethacin. PGE 2 and LTB 4 concentrations were measured in diluted samples (1:10) using enzyme immunoassay kits (Cayman Chemicals, Tallinn, Estonia) according to the manufacturer's recommendations. Results were expressed as ng/g of wet tissue.
iNOS activity was measured using a commercial kit (Cayman Chemicals). For this purpose, a second longitudinal colon stripe from each animal was homogenized in the buffer sample provided by the kit, and the assay was performed following the manufacturer's instructions. Data were expressed as a conversion percentage of [ 3 
H] arginine to [ 3 H] citrulline.
A third longitudinal colon stripe from each animal was homogenized in 1.15% KCl buffer containing 1% (v/v) butylhydroxytoluene at 100 g/L. TBARS concentration was determined as an index of lipid peroxidation, a major indicator of oxidative stress. Malondialdehyde (MDA) was used as a standard curve. Data were expressed as mmol MDA/g of wet tissue.
A fourth longitudinal colon stripe from each animal was deproteinized by homogenization with 5% trichloroacetic acid in sodium phosphate buffer pH 6.0 (50 g/L), and followed by three repeated freeze -thaw cycles. GSH content was quantified using the 5,5 0 -dithio-bis 2-nitrobenzoic acid (DTNB) recycling assay. 18 DTNB was used as standard and data were expressed as mmol/g of wet tissue.
Histological analysis
Colon segments were fixed in 10% buffered formaldehyde. Tissue samples were washed with tap water, dehydrated in increasing concentrations of ethanol (70% for one hour, 96% for one hour Â3) and embedded in paraffin. Tissue sections were cut (4 mm) on a microtome (Leitz, Wetzlar, Germany) and stained with the hematoxylin -eosin technique. Histological assessment was carried out in a blind fashion considering cell infiltration and goblet cell lost together with structural changes. Microphotographs were taken with an Olympus BX41 microscope (Olympus, Hamburg, Germany).
Statistical analysis
The software package SPSS 16.0 (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. Data were analyzed using one-way analysis of variance (ANOVA) followed by the Scheffé's post hoc significance test after having confirmed normality and equal variance assumptions by the Kolmogorov -Smirnov's and Levene's statistical tests, respectively. Differences were considered statistically significant at P values of ,0.05.
Results

Effects of cocoa diet on clinical signs of colitis
Rats receiving DSS developed colitis, which was assessed by the DAI (Figure 2 ). DAI increased during the first six days, remained stable for the following three days and decreased from day 9. No significant differences were observed among the DSS-C, DSS-Q and DSS groups.
Effects of cocoa diet on colon architecture after receiving DSS
The analysis of the intestine after 14 days of DSS treatment revealed a higher weight and a shorter length of the colon in the DSS, DSS-Q and DSS-C groups in comparison with that of the REF group. In consequence, the colon weight/ length ratio was significantly increased in the three groups (P , 0.05; Figure 3a ) without significant differences among them. The cocoa diet and the quercitrin treatment did not prevent the changes induced by DSS in the colon architecture. However, the microscopic analysis of the colon sections from animals of the DSS-Q and DSS-C groups showed only a moderate lamina propria mononuclear cell infiltration and the prevention of goblet cell loss in comparison with the DSS group (Figures 3b and e ).
Effects of cocoa diet on inflammatory and oxidant indicators from blood and colon
After 14 days of DSS treatment, the colonic inflammatory process was reflected by a marked leukocytosis in the DSS, DSS-Q and DSS-C groups when compared with the REF group (P , 0.05; Figure 4a ). This increase was due to both neutrophil and lymphocyte counts (Figures 4b and  c) , which were significantly higher in the DSS group than in the REF group (P , 0.05) and showed the same increased pattern in animals fed the cocoa diet. The leukocytosis in the DSS-Q group was mainly attributed to increased neutrophil counts since lymphocyte counts were similar to those found in the REF group.
Serum TNF-a concentration significantly increased in the DSS group compared with REF animals after 14 days of DSS drinking (P , 0.05; Table 2 ). Similar results were obtained in the DSS-Q group, which was treated with quercitrin. Interestingly, serum TNF-a increase was significantly prevented by the cocoa diet (P , 0.05).
The inflammatory response was also studied in colon homogenates by means of PGE 2 and LTB 4 concentrations and iNOS activity ( Table 2 ). The PGE 2 concentration was higher in the DSS group (P , 0.05) than in the REF group, and neither the cocoa diet nor the quercitrin treatment prevented such increase. Similarly, the LTB 4 concentration was increased in the DSS group compared with REF animals and no effect was detected in the cocoa diet group. However, quercitrin treatment tended to decrease the LTB 4 concentration. On the other hand, colon iNOS activity was slightly increased in the DSS and DSS-Q groups compared with that of the REF group, but, interestingly, cocoa-fed animals inhibited iNOS activity in the colon that was even lower than in the REF animals (P , 0.05).
With regards to oxidative status in the colon, we determined TBARS as a measure of lipid peroxidation and GSH content as an endogenous antioxidant. Both the quercitrin treatment and the cocoa diet tended to reduce the TBARS produced in the DSS group (Table 2) . GSH content was significantly decreased in the DSS group compared with the REF group (P , 0.05). The cocoa diet increased the colon GSH content (P , 0.05 versus DSS group), which was even higher than in the REF group. GSH content in the DSS-Q group was between that observed in the DSS and REF animals.
Effects of cocoa diet on MLNs and blood lymphocyte composition
In MLNs, the colon inflammation in the DSS group did not modify the percentage of Th, Tc, B, natural killer (NK), NKT, T reg and T act lymphocytes compared with the REF group (Figures 5a and c) . However, both the quercitrin-treated and cocoa-fed groups displayed a lower Th cell percentage than the REF group (P , 0.05), and the DSS-C group showed a higher B-cell proportion (P , 0.05) than the REF group.
In the blood, DSS administration did not significantly alter the proportion of Th, Tc and B cells (Figure 5d ) but did increase the percentages of NK and T reg cells, which were higher in the three DSS groups than in the REF group (P , 0.05, Figures 5e and f ) . The DSS-Q group showed the highest T reg proportion in Th cells and both the DSS-Q and DSS-C groups increased the proportion of T act subset in Th cells (P , 0.05). 
Effect of cocoa diet on small intestine S-IgA and S-IgM content
In the DSS group, the S-IgA content in the small intestine wash was not modified by the inflammatory process ( Figure 6 
Discussion
This paper assesses the impact of a dietary intervention with cocoa, as a source of antioxidant flavonoids, on the DSS model of rat colitis. In particular, we focused on the intestinal and systemic inflammatory response, including the oxidative status. A cocoa diet has been reported to show anti-inflammatory and immunomodulatory properties 11 -13 but there is a scarce number of studies describing the effects of cocoa on IBD. The effects observed were compared with those exerted by quercitrin, with recognized antioxidant and anti-inflammatory properties. 6 The results demonstrate that in our experimental conditions, cocoa intake and quercitrin treatment do not improve clinical colitis, although they certainly contributed to reducing colonic oxidative activity and tissue damage. Moreover, cocoa showed anti-inflammatory potential by down-regulating serum TNF-a concentration and colon iNOS activity and by decreasing colon cell infiltration.
The pathogenesis of IBD involves the recruitment of leukocytes into the intestinal mucosa. 19 Among them, macrophages secrete large amounts of inflammatory mediators and nitrogen and reactive oxygen species that induce oxidative stress. 19 In this line, we found that DSS-induced colitis produced consumption of glutathione and an increased lipid peroxidation in the colon. The cocoa diet avoided the glutathione consumption and partially prevented the lipid peroxidation. Similar results were obtained by quercitrin treatment, although neither the cocoa diet nor the quercitrin treatment reduced the clinical development of colitis. In agreement with our results, the antioxidant luteolin incorporated into the diet does not ameliorate and even worsens the DSS-induced colitis in NF-kB EGFP transgenic mice. 20 Moreover, consumption of a lemon verbena infusion rich in polyphenolic compounds did not improve the histopathological changes induced by 4% DSS in rats, despite stimulating the activity of the antioxidant enzyme superoxide dismutase and reducing lipid peroxidation in the colon. 21 However, it has been recently reported that a polyphenol-enriched cocoa extract was able to decrease acute DSS colitis in mice, 22 thus evidencing the promising anti-inflammatory effects of cocoa flavonoids. These results may also suggest that we did not observe a clear colitis reduction because of the lower polyphenol content in the cocoa that we used.
On the other hand, as we have confirmed here, colitis is associated with increases in the inflammatory mediators LTB 4 and PGE 2 . 23 However, neither cocoa nor quercitrin treatment could avoid such increases. Another indicator of the inflammatory process in the colon and macrophage infiltrates is the iNOS activity. 6 Although we found no higher iNOS activity in animals receiving DSS, interestingly, the cocoa-fed group showed lower iNOS activity than the DSS group. Similarly, the cocoa diet prevented the increase in serum TNF-a concentration, a key molecule in IBD pathogenesis. 24 Both protective effects on iNOS and TNF-a are in line with previous in vitro and in vivo studies, 11,25 but they could not contribute to attenuate the intestinal inflammatory process.
In order to assess the effects of cocoa on the inflammatory process beyond the colon, cell composition was established in the blood and MLNs. There is limited information about the impact of DSS on the cell populations of these compartments in rat. In our study, the inflammatory process did not vary the proportion of Th, Tc, B, NK, NKT, T reg and T act lymphocytes in the MLNs. However, the cocoa diet increased the proportion of B lymphocytes, and both the cocoa diet and the quercitrin treatment reduced the proportion of Th cells in the MLNs. The results from the cocoa intake by the colitic animals are in line with the effects observed in the MLNs of cocoa-fed healthy animals. 13 In any case, the decrease of the proportion of Th cells did not involve clinical recovery, which could be attributed to the fact that Th or B-cells may not be essential in DSS colitis, as shown in immunodeficient mice. 26 On the other hand, we found no significant changes in the MLN percentage of T reg cells, contrary to recent studies showing a decrease of T reg subset in the MLNs of mice that received 5% DSS in their drink for seven days. 27 In the blood compartment, we found that the intestinal inflammatory process produced neutrophilia and lymphocytosis but the proportions of the main lymphocyte subsets were not modified. However, the NK cell percentage increased in the blood of the DSS animals. This finding is consistent with the fact that depletion of NK cells attenuates the severity of acute colitis in DSS-treated mice 28 and suggests an important role of these cells in colitis. Neither the cocoa diet nor the quercitrin treatment prevented the increase of the blood NK cell proportion, which could be one of the reasons why cocoa-fed animals did not display colitis amelioration in spite of showing antioxidant activity in the colon and reduced serum TNF-a. Regarding the T reg subpopulation, the inflammatory process unexpectedly increased the percentage of T reg cells in Th lymphocytes in the blood. The T reg increase might be seen as an attempt to re-establish intestinal homeostasis under inflammatory conditions.
Although the exact mechanism through which DSS initiates colitis remains unknown, different studies suggest that DSS administration may compromise the gut epithelial barrier function, resulting in an increased permeability. 14 The mucosal IgA system contributes to the barrier functionality, generating immune protection in a non-inflammatory manner. The cocoa diet significantly decreased the S-IgA and S-IgM in the small gut as previously reported in healthy animals. 13 Although in our study the colonic S-IgA concentration was not assessed, the down-regulatory effect on S-IgA of the small intestine may have also occurred in the colon of cocoa-fed animals. In fact, previous studies have reported decreased S-IgA concentration in the feces of healthy animals fed with a diet containing 5% of cocoa. 29 Therefore, it could be suggested that the cocoa diet, although exerting antioxidant and even anti-inflammatory protection, may increase colon permeability by reducing S-IgA content, which may contribute to the inflammatory process. In other words, those beneficial effects of cocoa flavonoids may have been counteracted by a decreased S-IgA protection in the colon.
In conclusion, a diet containing cocoa may help to manage the oxidative stress consequent to colitis, although this action is not enough to reverse the inflammatory process. Cocoa intake shows anti-inflammatory potential and seems to decrease colon cell infiltration. Therefore, the cocoa diet may be considered as a promising complementary therapy for IBD. 
